NCT06597370View on ClinicalTrials.gov

Immunogenicity Induced by COVID-19 Vaccines in Mexican Population

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

December 20, 2021

Study Completion Date

December 21, 2021

Conditions
COVID-19 Vaccine
Interventions
OTHER

Gene expression mRNA of IgG anti-spike

"b) Peripheral venous blood samples (3 ml per occasion) will be taken from all participants. They will be carried out on days 30,60 and 120 after completion of the COVID-19 vaccination schedule.~c) Sample processing:~* tRNA extraction from all samples.~* cDNA synthesis~* Real time PCR performance."

Trial Locations (1)

11340

Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City

All Listed Sponsors
lead

National Polytechnic Institute, Mexico

OTHER

NCT06597370 - Immunogenicity Induced by COVID-19 Vaccines in Mexican Population | Biotech Hunter | Biotech Hunter